新型氮杂环卡宾银(Ⅰ)配合物的合成及其晶体结构

以取代苄氯(1a~1c)为起始原料,与咪唑经氮烷基化反应制得苄基咪唑氯盐(2a~2c);2a~2c与氧化银经原位去质子化反应合成了3种新型的氮杂环卡宾银配合物——(NHC)AgCl[NHC:1,3-二(4-甲氧基苄基)咪唑-2-亚基(3a),1,3-二(3-甲氧基苄基)咪唑-2-亚基(3b)]和[(NHC)AgCl]_2[NHC=1,3-二(4-氯苄基)咪唑-2-亚基(3c)],其结构经~1H NMR,~(13)C NMR,IR,元素分析和X-射线单晶衍射表征。3a~3c单晶结构均属单斜晶系,3a为P21/n空间群,3b和3c为P21/c空间群,3a和3b为单核银配合物,3c为双核银配合物。     

镍(Ⅱ)基双氮杂环卡宾配合物的合成及其晶体结构

以咪唑和取代氯化苄为原料,经氮烷基化反应合成三个氮杂环卡宾(NHC)配体[L1:N,N-二苄基咪唑-2-亚基,L2:N,N-二(4-甲基苄基)咪唑-2-亚基,L3:N,N-二(4-氯苄基)咪唑-2-亚基];再以咪唑官能团化的N-杂环卡宾配体和氯化镍为原料,通过金属交换反应合成三个新型的镍基双氮杂环卡宾配合物[Ni(NHC)_2]Cl_2(C1~C3),其结构经~1H NMR,IR,元素分析和X-单晶射线衍射表征。配合物C1和C3属于单斜晶系,分别为P2_1/n和P2_1/c空间群。配合物C2属于三斜晶系,为P1空间群。C1~C3的CCDC分别为:1433176,1433177和1433179。     

基于3,5-吡啶二羧酸和双咪唑配体构筑的锌(Ⅱ)配位聚合物的合成、晶体结构及其荧光性质

以1,3-双咪唑丙烷,3,5-吡啶二羧酸和Zn(NO₃)₂·6H₂O为原料,在水热条件下合成了一个新的Zn(Ⅱ)配合物{［Zn(bbi)(3,5-pdc)］·2H₂O}_n(1, bbi=1,3-二咪唑丙烷,3,5-pdc=3,5-吡啶二羧酸), 其结构和热性能经IR, 元素分析,Ｘ-射线单晶衍射和TGA表征。1属三斜晶系,P-1空间群,晶胞参数a=9.070 8(5) , b=10.213 1(8), c=11.266 7(7), α=82.138(6)°,β=89.368(5)°, γ=75.419(6)°。室温固态荧光测试结果显示,在330 nm激发态下,1在424 nm具有强烈的荧光发射峰。     

吡啶盐/咪唑盐调控钴萘基二膦酸配位聚合物的结构和性质

通过引入质子化的1,3-二(4-吡啶基)丙烷(1,3-dppH₂²⁺)和双(咪唑-1-甲基)苯(1,4-bixH₂²⁺)作为阳离子模板,采用水热反应,得到3种基于1,4-萘二膦酸(1,4-ndpaH₄)配体的钴萘二膦酸配位聚合物：(1,3-dppH₂)₂[Co₄(1,4-ndpa)(1,4-ndpaH)₂(1,4-ndpaH₂)]·6H₂O (1)、(1,4-bixH₂)_0.5[Co(1,4-ndpaH)](2)和(1,4-bixH₂)_0.5[Co₂(1,4-ndpaH)(1,4-ndpaH₂)(H₂O)₂](3)。对配合物1～3分别进行了元素分析、红外光谱、单晶X射线衍射、...     

新型苯并咪唑类配体配合物的合成及其性能

以苯并咪唑（HL¹）和3,6 二氯哒嗪在钠催化下反应制得配体3-氯-6-(苯并咪唑-1-基)哒嗪(L²）;采用溶液法和水热法,L¹分别与含有银、铜过渡金属盐反应合成了3种新的有机金属苯并咪唑配合物［AgL¹］_n(1),［Cu₄(HL¹)₄(O)(Cl)₆］(2)和{［Cu(HL¹)₂］·SiF₆}(3);采用溶液法,L²与Zn(NO₃)₂·6H₂O经配位反应合成了配合物{［Zn(L²)₃(NO₃)］NO₃}(4),其结构经IR,元素分析和X-射线单晶衍射表征。结果表明：1通过苯并咪唑桥连形成一维链状结构,2由苯并咪唑和氯离子桥接形成四核结构,3和4均显示一个单核结构,3的金属中心原子采用二配位构型,4的金属中心原子采用四配位构型。此外,研究了配体HL¹与1,及配体L²与4的荧光性能。结果表明：与HL¹相比,1的最大发射波长发生了红移;而4相对于配体L²其最大发射峰发生明显蓝移。     

铬酸根桥联Cu(Ⅱ)/Ni(Ⅱ)链状配位聚合物的合成及性质

设计合成了2个一维链状铬酸根桥连的配位聚合物(NH₄)₂[Cu(NH₃)₂(CrO₄)₂](1)和(NH₄)₂·[Ni(NH₃)₂(CrO₄)₂](2), 并对其进行了X射线单晶结构分析、 热重-差热分析和多种磁学测试. 晶体结构分析表明, 2个配合物的晶体均属于三斜晶系, 空间群均为P1. 配合物1的晶胞参数为: a=0.59090(12)nm, b=0.6929(3) nm, c=0.73740(15) nm, α=107.03(4)°, β=92.79(3)°, γ=112.44(2)°; 配合物2的晶胞参数为: a=0.56987(7)nm, b=0.69972(9) nm, c=0.73335(8)nm, α=104.929(3)°, β=96.121(3)°, γ=112.325(4)°. 热重分析结果表明, 配合物1和2均在150 ℃左右开始分解, 生成H₂Cr₂CuO₅和H₂Cr₂NiO₅, 在410 ℃以上继续分解, 脱水得到相应的氧化物. 配合物的变温磁化率测试结果表明, 相邻Cu(Ⅱ)离子(配合物1)或Ni(Ⅱ)离子(配合物2)之间存在较弱的反铁磁相互作用; 低温变场和交流磁化率测试结果表明, 2个配合物均为反铁磁体.     

新型离子型配合物的合成、晶体结构及性质

利用水热法合成了4-(N,N′-双(4-羧基苄基)氨基)苯磺酸（H₃L）的两个离子型配合物：[Mn(phen)₂(H₂O)₂]?(HL)?(H₂O)₄（1）和[Zn(phen)₂(H₂O)₂]?(HL)?(H₂O)₆（2, phen =邻菲罗啉）,其结构经FL、 IR、元素分析、X-射线单晶衍射、 X-射线粉末衍射和TG表征。结果表明：化合物1属于单斜晶体,P2₁/c空间群,晶胞参数a=11.997(1) Å, b=22.978(1) Å, c=18.093(1) Å, β=92.749(3)°, V=4981.8(3) ų, Z=4。化合物2属于单斜晶体,P2₁/c空间群,晶胞参数a=11.861(1) Å, b=22.816(1) Å, c=18.251(1) Å, β=92.832(5)°, V=4932.8(5) ų,Z=4。化合物2有较好的荧光性质;初始分解温度为80 ℃。      

氮杂环卡宾配位的单核型一价铁硫酚基配合物

含硫配体的低价铁物种被认为是固氮酶配位活化氮气时的活性金属物种, 但与之相关的含硫配体的单核型低价铁配合物的合成非常具有挑战性, 报道很少. 我们发现通过含氮杂环卡宾配体的三配位一价铁配合物(IMes)₂FeBr (IMes=1,3-bis(mesityl)imidazole-2-ylidene)与大位阻硫醇钾KSAr* (Ar*=2,6-(2',4',6'-Prⁱ₃C₆H₂)₂C₆H₃)的反应可以合成得到单核型一价铁硫酚基配合物[(IMes)Fe(SAr*)] (1). 配合物1为顺磁性配合物. 单晶X-射线衍射表征显示该一价铁配合物的铁中心除与一个氮杂环卡宾配位外还与大位阻硫酚配体的硫原子和2-位芳环以σ:η⁶-的方式配位. ⁵⁷Fe-穆斯堡尔谱、电子顺磁共振谱和理论计算共同表明配合物1的基态自旋量子数S=1/2. 配合物1可催化N₂与KC₈和Me₃SiCl反应, 生成N(SiMe₃)₃, 转换数(TON)可达87.     

二茂铁基功能化的氮杂环卡宾银配合物的合成及催化活性

通过N-二茂铁基甲基-N-吡啶基甲基咪唑盐与氧化银在相转移催化条件下反应, 合成了4个二茂铁基功能化的氮杂环卡宾银配合物(NHC)₂AgX(X=PF₆或BF₄), 并利用NMR及X-射线单晶衍射对其结构进行了表征. 在这4个化合物中, 银为二配位结构, 吡啶氮原子并未参与配位. 催化活性测试结果表明, 合成的4个化合物具有高的催化炔、 醛和胺三组分偶联反应活性.     

钒氧多酸桥联大环铜配合物的合成及其晶体结构

以大环铜配合物［CuL］(ClO₄)₂(L=5,7,7,12,14,14-六甲基-1,4,8,11-四氮杂环十四-4,11-二烯)与NH₄VO₃反应合成了一个新的钒氧多酸桥联大环铜配合物［CuL］₂［H₂V₁₀O₂₈］·7H₂O(1),其结构经IR,元素分析和X-射线单晶衍射表征。1（CCDC: 1510831）属单斜晶系,P2(1)/n空间群,晶胞参数a=11.512(3) , b=18.170(4) , c=14.534(3) , β=102.997(4)°, V=2 962.3(11) ³, Dc=1.986 mg·cm^-3, Z=2, μ=2.300 mm^-1, R₁=0.047 2, wR₂=0.118 2。     

Anellated N-heterocyclic carbenes: 1,3-dineopentylnaphtho[2,3-d]imidazol-2-ylidene: synthesis, KOH addition product, transition-metal complexes, and anellation effects

Two novel anellated N-heterocyclic carbenes (NHC), 1,3-dineopentylnaphtho[2,3-d]imidazol-2-ylidene, and 1,3-dineopentyl-2-ylido-imidazolo[4,5-b]pyridine were obtained by reduction of the respective thiones with potassium, the former also by deprotonation of the corresponding naphthimidazolium hexafluorophosphate by using excess KH in THF. The use of equimolar amounts of KH provided an unexpected formal addition product of this NHC with KOH. X-ray crystal structure analysis of the adduct provided evidence for a distorted tetrameric N-heterocyclic alkoxide, stabilized by two THF molecules. In C(6)D(6) the compound undergoes disproportionation. Transition-metal complexes [(NHC)AgCl], [(NHC)Rh(cod)Cl], and (E)-[(NHC)(2)PdCl(2)] of the novel naphthimidazol-2-ylidene were synthesized. X-ray crystal structures and (1)H and (13)C NMR spectroscopic data provided detailed structural information. Comparing characteristic data with those of nonanellated and differently anellated NHCs or their complexes provides information on the influence of the extended anellation.     

1,3-dialkyl- and 1,3-diaryl-3,4,5,6-tetrahydropyrimidin-2-ylidene rhodium(i) and palladium(II) complexes: synthesis, structure, and reactivity

The synthesis of novel 1,3-diaryl- and 1,3-dialkylpyrimidin-2-ylidene-based N-heterocyclic carbenes (NHCs) and their rhodium(i) and palladium(II) complexes is described. The rhodium compounds bromo(cod)[1,3-bis(2-propyl)-3,4,5,6-tetrahydropyrimidin-2-ylidene]rhodium (7), bromo(cod)(1,3-dimesityl-3,4,5,6-tetrahydropyrimidin-2-ylidene)rhodium (8) (cod=eta(4)-1,5-cyclooctadiene, mesityl=2,4,6-trimethylphenyl), chloro(cod)(1,3-dimesityl-3,4,5,6-tetrahydropyrimidin-2-ylidene)rhodium (9), and chloro(cod)[1,3-bis(2-propyl)-3,4,5,6-tetrahydropyrimidin-2-ylidene]rhodium (10) were prepared by reaction of [[Rh(cod)Cl](2)] with lithium tert-butoxide followed by addition of 1,3-dimesityl-3,4,5,6-tetrahydropyrimidinium bromide (3), 1,3-dimesityl-3,4,5,6-tetrahydropyrimidinium tetrafluoroborate (4), 1,3-di-2-propyl-3,4,5,6-tetrahydropyrimidinium bromide (6), and 1,3-di-2-propyl-3,4,5,6-tetrahydropyrimidinium tetrafluoroborate, respectively. Complex 7 crystallizes in the monoclinic space group P2(1)/n, and 8 in the monoclinic space group P2(1). Complexes 9 and 10 were used for the synthesis of the corresponding dicarbonyl complexes dicarbonylchloro(1,3-dimesityl-3,4,5,6-tetrahydropyrimidin-2-ylidene)rhodium (11), and dicarbonylchloro[1,3-bis(2-propyl)-3,4,5,6-tetrahydropyrimidin-2-ylidene]rhodium (12). The wavenumbers nu(CO I)/nu(CO II) for 11 and 12 were used as a quantitative measure for the basicity of the NHC ligand. The values of 2062/1976 and 2063/1982 cm(-1), respectively, indicate that the new NHCs are among the most basic cyclic ligands reported so far. Compounds 3 and 6 were additionally converted to the corresponding cationic silver(i) bis-NHC complexes [Ag(1,3-dimesityl-3,4,5,6-tetrahydropyrimidin-2-ylidene)(2)]AgBr(2) (13) and [Ag[1,3-bis(2-propyl)-3,4,5,6-tetrahydropyrimidin-2-ylidene](2)]AgBr(2) (14), which were subsequently used in transmetalation reactions for the synthesis of the corresponding palladium(II) complexes Pd(1,3-dimesityl-3,4,5,6-tetrahydropyrimidin-2-ylidene)(2) (2+)(Ag(2)Br(2)Cl(4) (4-))(1/2) (15) and Pd[1,3-bis(2-propyl)-3,4,5,6-tetrahydropyrimidin-2-ylidene)(2)]Cl(2) (16). Complex 15 crystallizes in the monoclinic space group P2(1)/c, and 16 in the monoclinic space group C(2)/c. The catalytic activity of 15 and 16 in Heck-type reactions was studied in detail. Both compounds are highly active in the coupling of aliphatic and aromatic vinyl compounds with aryl bromides and chlorides with turnover numbers (TONs) up to 2000000. Stabilities of 15 and 16 under Heck-couplings conditions were correlated with their molecular structure. Finally, selected kinetic data for these couplings are presented.     

Chemistry surrounding monomeric copper(I) methyl, phenyl, anilido, ethoxide, and phenoxide complexes supported by N-heterocyclic carbene ligands: reactivity consistent with both early and late transition metal systems

Monomeric copper(I) alkyl complexes that possess the N-heterocyclic carbene (NHC) ligands IPr, SIPr, and IMes [IPr = 1,3-bis(2,6-diisopropylphenyl)imidazol-2-ylidene, SIPr = 1,3-bis(2,6-diisopropylphenyl)imidazolin-2-ylidene, IMes = 1,3-bis(2,4,6-trimethylphenyl)imidazol-2-ylidene] react with amines or alcohols to release alkane and form the corresponding monomeric copper(I) amido, alkoxide, or aryloxide complexes. Thermal decomposition reactions of (NHC)Cu(I) methyl complexes at temperatures between 100 and 130 degrees C produce methane, ethane, and ethylene. The reactions of (NHC)Cu(NHPh) complexes with bromoethane reveal increasing nucleophilic reactivity at the anilido ligand in the order (SIPr)Cu(NHPh) < (IPr)Cu(NHPh) < (IMes)Cu(NHPh) < (dtbpe)Cu(NHPh) [dtbpe = 1,2-bis(di-tert-butylphosphino)ethane]. DFT calculations suggest that the HOMO for the series of Cu anilido complexes is localized primarily on the amido nitrogen with some ppi(anilido)-dpi(Cu) pi-character. [(IPr)Cu(mu-H)]2 and (IPr)Cu(Ph) react with aniline to quantitatively produce (IPr)Cu(NHPh)/dihydrogen and (IPr)Cu(NHPh)/benzene, respectively. Analysis of the DFT calculations reveals that the conversion of [(IPr)Cu(mu-H)]2 and aniline to (IPr)Cu(NHPh) and dihydrogen is favorable with DeltaH approximately -7 kcal/mol and DeltaG approximately -9 kcal/mol.     

Controlled synthesis of nickel(II) dihalides bearing two different or identical N-heterocyclic carbene ligands and the influence of carbene ligands on their structures and catalysis

Ni(II) dihalides bearing two different or identical NHC ligands have been prepared via a controlled indene elimination synthesis, and the former product provides a new route for the design of biscarbene Ni(II)-based catalysts. The indene elimination reaction of the indenynickel(II) complex (1-H-Ind)Ni(NHC)X (Ind = indenyl) with one equiv. of a distinct imidazolium salt at 100 °C afforded the first example of Ni(II) dihalides bearing two different NHC ligands, i.e., Ni(iPr)(IPr)X(2) [iPr = 1,3-diisopropylimidazol-2-ylidene, IPr = 1,3-bis(2,6-diisopropylphenyl)imidazol-2-ylidene), X = Cl, 1; X = Br, 2] and Ni(iPr)(IMes)Br(2) [IMes = 1,3-bis(mesityl)imidazol-2-ylidene, 3]. Alternatively, complexes 1-3 can be synthesized using a bis-indenyl Ni(II) complex (1-H-Ind)(2)Ni as starting materials via a step-by-step indene elimination at different reaction temperatures. The direct reaction of (1-R-Ind)(2)Ni (R = H or Me) with two equiv. of imidazolium salts at 100 °C afforded Ni(II) dihalides bearing two identical NHC ligands, i.e., Ni(iPr)X(2) (X = Cl, 4; X = Br, 5) and Ni(IPr)Cl(2) (6). All of these complexes were characterized by elemental analysis, NMR spectroscopy and X-ray crystallography for complexes 1-5. The two identical or different NHC ligands in complexes 1-6 changed the coordination sphere of the nickel center from a typical square-planar geometry to a slightly tetrahedral array. A preliminary catalytic study on the cross-coupling reactions of aryl Grignard reagents with aryl halides revealed that complexes 1 and 2 possess the highest activity. In comparison, complexes 3 and 6 exhibited moderate activity and the least active complexes were 4 and 5.     

The reactivity of N-heterocyclic carbenes and their precursors with [Ru(3)(CO)(12)

The ambient temperature reaction of the N-heterocyclic carbenes (NHCs) 1,3-dimesitylimidazol-2-ylidene (IMes) and 1,3-bis(2,6-diisopropylphenyl)imidazol-2-ylidene (IDipp) with the triruthenium cluster [Ru(3)(CO)(12)], in a 3 : 1 stoichiometric ratio, results in homolytic cleavage of the cluster to quantitatively afford the complexes [Ru(CO)(4)(NHC)] (; NHC = IMes, ; NHC = IDipp). Reaction of the 2-thione or hydrochloride precursors to IMes, i.e. S[double bond, length as m-dash]IMes and IMes.HCl, with the same triruthenium cluster affords the complexes [Ru(4)(mu(4)-S)(2)(CO)(9)(IMes)(2)] () and [Ru(4)(mu(4)-S)(CO)(10)(IMes)(2)] () (3 : 1 and 2 : 1 reaction), and [{Ru(mu-Cl)(CO)(2)(IMes)}(2)] () (3 : 1 reaction) respectively. By contrast, the complex [Ru(3)(mu(3)-S)(2)(CO)(7)(IMeMe)(2)] (), where IMeMe is 1,3,4,5-tetramethylimidazol-2-ylidene, is the sole product of the 2 : 1 stoichiometric reaction of S[double bond, length as m-dash]IMeMe with [Ru(3)(CO)(12)]. Compounds -, and have been structurally characterised by single crystal X-ray diffraction.     

Syntheses, crystal structures, reactivity, and photochemistry of gold(III) bromides bearing N-heterocyclic carbenes

Gold(I) complexes bearing N-heterocyclic carbenes (NHC) of the type (NHC)AuBr (3a/3b) [NHC = 1-methyl-3-benzylimidazol-2-ylidene (= MeBnIm), and 1,3-dibenzylimidazol-2-ylidene (= Bn(2)Im)] are prepared by transmetallation reactions of (tht)AuBr (tht = tetrahydrothiophene) and (NHC)AgBr (2a/2b). The homoleptic, ionic complexes [(NHC)(2)Au]Br (6a/6b) are synthesized by the reaction with free carbene. Successive oxidation of 3a/3b and 6a/6b with bromine gave the respective (NHC)AuBr(3) (4a/4b) and [(NHC)(2)AuBr(2)]Br (7a/7b) in good overall yields as yellow powders. All complexes were characterized by NMR spectroscopy, mass spectrometry, elemental analysis and single crystal X-ray diffraction. Reactions of the Au(III) complexes towards anionic ligands like carboxylates, phenolates and thiophenolates were investigated and result in a complete or partial reduction to a Au(I) complex. Irradiation of the Au(III) complexes with UV light yield the Au(I) congeners in a clean photo-reaction.     

Stoichiometric and catalytic reactivity of the N-heterocyclic carbene ruthenium hydride complexes [Ru(NHC)(L)(CO)HCl] and [Ru(NHC)(L)(CO)H(eta2-BH4)] (L=NHC, PPh3)

Thermolysis of [Ru(AsPh3)3(CO)H2] with the N-aryl heterocyclic carbenes (NHCs) IMes (1,3-bis(2,4,6-trimethylphenyl)imidazol-2-ylidene), IPr (1,3-bis(2,6-diisopropylphenyl)imidazol-2-ylidene) or the adduct SIPr.(C6F5)H (SIPr=1,3-bis(2,6-diisopropylphenyl)-4,5-dihydroimidazol-2-ylidene), followed by addition of CH2Cl2, affords the coordinatively unsaturated ruthenium hydride chloride complexes [Ru(NHC)2(CO)HCl] (NHC=IMes , IPr , SIPr ). These react with CO at room temperature to yield the corresponding 18-electron dicarbonyl complexes . Reduction of and [Ru(IMes)(PPh3)(CO)HCl] () with NaBH4 yields the isolable borohydride complexes [Ru(NHC)(L)(CO)H(eta2-BH4)] (, L=NHC, PPh3). Both the bis-IMes complex and the IMes-PPh3 species react with CO at low temperature to give the eta1-borohydride species [Ru(IMes)(L)(CO)2H(eta1-BH4)] (L=IMes , PPh3), which can be spectroscopically characterised. Upon warming to room temperature, further reaction with CO takes place to afford initially [Ru(IMes)(L)(CO)2H2] (L=IMes, L=PPh3) and, ultimately, [Ru(IMes)(L)(CO)3] (L=IMes , L=PPh3). Both and lose BH3 on addition of PMe2Ph to give [Ru(IMes)(L)(L')(CO)H2](L=L'=PMe2Ph; L=PPh3, L'=PMe2Ph). Compounds and have been tested as catalysts for the hydrogenation of aromatic ketones in the presence of (i)PrOH and H2. For the reduction of acetophenone, catalytic activity varies with the NHC present, decreasing in the order IPr>IMes>SIMes.     

Synthesis and biological activity of ester- and amide-functionalized imidazolium salts and related water-soluble coinage metal N-heterocyclic carbene complexes

N-Heterocyclic carbene (NHC) ligand precursors, namely, HIm(A)Cl [1,3-bis(2-ethoxy-2-oxoethyl)-1H-imidazol-3-ium chloride] and HIm(B)Cl {1,3-bis[2-(diethylamino)-2-oxoethyl]-1H-imidazol-3-ium chloride}, functionalized with hydrophilic groups on the imidazole rings have been synthesized and were used in the synthesis of corresponding carbene complexes of silver(I) and copper(I), {[Im(A)]AgCl}, {[Im(A)]CuCl}, and {[Im(B)](2)Ag}Cl. Related Au(I)NHC complexes {[Im(A)]AuCl} and {[Im(B)]AuCl} have been obtained by transmetalation using the silver carbene precursor. These compounds were characterized by several spectroscopic techniques including NMR and mass spectroscopy. HIm(B)Cl and the gold(I) complexes {[Im(A)]AuCl} and {[Im(B)]AuCl} were also characterized by X-ray crystallography. The cytotoxic properties of the NHC complexes have been assessed in various human cancer cell lines, including cisplatin-sensitive and -resistant cells. The silver(I) complex {[Im(B)](2)Ag}Cl was found to be the most active, with IC(50) values about 2-fold lower than those achieved with cisplatin in C13*-resistant cells. Growth-inhibitory effects evaluated in human nontransformed cells revealed a preferential cytotoxicity of {[Im(B)](2)Ag}Cl versus neoplastic cells. Gold(I) and silver(I) carbene complexes were also evaluated for their ability to in vitro inhibit the enzyme thioredoxin reductase (TrxR). The results of this investigation showing that TrxR appeared markedly inhibited by both gold(I) and silver(I) derivatives at nanomolar concentrations clearly point out this selenoenzyme as a protein target for silver(I) in addition to gold(I) complexes.     

Series of mixed valent Fe(II)Fe(I) complexes that model the Hox state of [FeFe]hydrogenase: redox properties, density-functional theory investigation, and reactivities with extrinsic CO

A series of asymmetrically disubstituted models of the active site of [FeFe]-hydrogenase, (mu-pdt)[Fe(CO) 2PMe 3][Fe(CO) 2NHC] (pdt = 1,3-propanedithiolate, NHC = IMes, 1,3-bis(2,4,6-trimethylphenyl)imidazol-2-ylidene IMes ( 1), IMesMe, 1-methyl,3-(2,4,6-trimethylphenyl)imidazol-2-ylidene ( 2) or IMe, 1,3-bis(methyl)imidazol-2-ylidene ( 3)), have been synthesized and characterized. The one-electron oxidation of these complexes to generate mixed valent models of the H ox state of [FeFe]-hydrogenase, such as the previously reported (mu-pdt)(mu-CO)[Fe(CO) 2PMe 3][Fe(CO)IMes] (+) ( 1 ox ) (Liu, T.; Darensbourg, M. Y. J. Am. Chem. Soc. 2007, 129, 7008-7009) has been examined to explore the steric and electronic effects of different N-atom substituents on the stability and structure of the mixed valent cations. The differences in spectroscopic properties, structures, and relative stabilities of 1 ox , (mu-pdt)[Fe(CO) 2PMe 3][Fe(CO) 2IMesMe] (+) ( 2 ox ), and (mu-pdt)[Fe(CO) 2PMe 3]-[Fe(CO) 2IMe] (+) ( 3 ox ) are discussed in the context of both experimental and theoretical data. Of the three derivatives, only that with greatest steric bulk on the NHC ligand, 1 ox , shows a clear indication of a mu-CO by solution nu(CO) IR and yields to crystallization as a rotated form, commensurate with the two-Fe subsite of H ox. In addition, the reactivity of the complexes with extrinsic CO to form CO adducts and/or exchange with (13)CO is explored by experiment and by using density-functional theory calculations.